Clinical Trials Browser

Phase 3 × OTHER × Thymalfasin × Clear all

NCT05086614 2021-10-21

Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms